Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension ∗-Reference-Cited by-同舟云学术

Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension ∗

Published:2020-06-26 Issue:10 Volume:38 Page:1919-1928
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Mulatero Paolo,Monticone Silvia,Deinum Jaap,Amar Laurence,Prejbisz Aleksander,Zennaro Maria-Christina,Beuschlein Felix,Rossi Gian Paolo,Nishikawa Tetsuo,Morganti Alberto,Seccia Teresa Maria,Lin Yen-Hung,Fallo Francesco,Widimsky Jiri

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference81 articles.

1. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017;Lancet,2018

2. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis;Ettehad;Lancet,2016

3. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension;Olsen;Lancet,2016

4. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries;Chow;JAMA,2013

5. Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice;Monticone;J Am Coll Cardiol,2017

Cited by 187 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. [131I]6ß-Iodomethyl-19-norcholesterol SPECT/CT for the Lateralization of Mineralocorticoid Overproduction in Primary Aldosteronism;Diagnostics;2024-09-09

2. Adrenal incidentalomas;Vnitřní lékařství;2024-09-04

3. Genetic testing for familial hyperaldosteronism type 1 in Aotearoa/New Zealand;Internal Medicine Journal;2024-08-31

4. Safety and efficacy of bilateral superselective adrenal arterial embolization for treatment of idiopathic hyperaldosteronism: a prospective single-center study;BMC Surgery;2024-08-24

5. Historical changes in the clinical features of primary aldosteronism;Hypertension Research;2024-08-08